{"id":482145,"date":"2020-05-04T07:00:02","date_gmt":"2020-05-04T07:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=482145"},"modified":"2020-05-04T07:00:02","modified_gmt":"2020-05-04T07:00:02","slug":"deep-brain-stimulation-market-outlook-investors-still-miss-the-big-assessment-stay-tuned-for-latest-update","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/deep-brain-stimulation-market-outlook-investors-still-miss-the-big-assessment-stay-tuned-for-latest-update_482145.html","title":{"rendered":"Deep Brain Stimulation MARKET OUTLOOK: INVESTORS STILL MISS THE BIG ASSESSMENT | STAY TUNED FOR LATEST UPDATE"},"content":{"rendered":"
\"Deep<\/a><\/p>\n
\n
Deep Brain Stimulation Market is expected to reach USD 1481.39 Million by 2025 with the CAGR of 8.50% over the forecast period.<\/div>\n<\/div>\n<\/div>\n
The Deep Brain Stimulation report provides independent information about the Deep Brain Stimulation industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porter\u2019s five force analysis, and key companies profiles including business overview and recent development.<\/div>\n

Deep Brain Stimulation Market is expected to reach USD 1481.39 Million by 2025 with the CAGR of 8.50% over the forecast period.<\/strong><\/span><\/em><\/strong><\/p>\n

Deep Brain Stimulation Market<\/strong><\/a> Increasing geriatric population and rising prevalence of brain related diseases coupled with technological advancement are some of the key drivers responsible for the growth of Deep Brain Stimulation Market.<\/p>\n

Key Players for Global Deep Brain Stimulation Market Reports – <\/strong>Global Deep Brain Stimulation market reports covers prominent players are Medtronic Plc, St. Jude Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Aleva Neurotherapeutics, Soterix Medical Inc., Bioinduction Ltd., and SceneRay Corporation and others.<\/p>\n

Get Sample Copy of This Premium Report @<\/strong> https:\/\/brandessenceresearch.com\/requestSample\/PostId\/289<\/a> <\/p>\n

Scope of Global Deep Brain Stimulation Market Reports –<\/strong> Deep brain stimulation involves using a pacemaker-like device called “neurostimulator” to deliver constant electrical stimulation to problematic areas within the brain. It is widely used to treat a number of neurological and psychiatric conditions, such as Parkinson’s disease, dystonia, essential tremor epilepsy, Tourette syndrome, chronic pain, obsessive compulsive disorder and others. It has been used to treat over more than 40,000 people with Parkinson’s disease and essential tremor worldwide. So during the study of global Deep Brain Stimulation market, we have considered deep brain stimulation devices and consumables to analyze the market.<\/p>\n

Abbott’s device-controlled deep brain stimulation system receives expanded indication for Parkinson’s treatment.<\/p>\n

June 27, 2020: -Abbott’s Infinity Deep Brain Stimulation (DBS) system has been received an expanded clearance from the FDA that now permits the targeted stimulation of a new area of the brain associated with Parkinson’s disease symptoms. Through now targeting the internal Globus Pallidus alongside the sub thalamic nucleus and ventral intermediate nucleus, the company says that its system is now the only directional DBS system approved for all major targets used to treat movement disorders, Parkinson’s disease and essential tremor. The Infinity Deep Brain Stimulation system connects via Bluetooth to an iPad mini, through which clinicians can program their patient’s therapy and monitor outcomes on Abbott’s software platform. Patients, meanwhile, manage their systems using an iPod touch-powered controller for the device. The system has a CE Mark, and according to Abbott, it is available in nearly 30 countries.<\/p>\n

Global Deep Brain Stimulation market report is segmented on the basis of DBS type, application type, end user type and by regional & country level. Based upon DBS type, global Deep Brain Stimulation market is classified as Thalamus, Sub-thalamus Nucleus (STN), Pedunculopontine Nucleus (PPN) and Globus Pallidus (GPi). Based upon application type, global Deep Brain Stimulation market is classified as Parkinson’s disease, dystonia, essential tremor epilepsy, Tourette syndrome, chronic pain, obsessive compulsive disorders and others. Based on end user type the Global Deep Stimulation market is classified as Hospitals and Ambulatory Surgical Centers (ASCs)<\/p>\n

The regions covered in this Deep Brain Stimulation market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Deep Brain Stimulation is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.<\/p>\n

Request for Methodology Report @ <\/strong>https:\/\/brandessenceresearch.com\/requestMethodology\/PostId\/289<\/a><\/p>\n

Global Deep Brain Stimulation Market Dynamics –<\/strong> According to the statistics of Parkinson’s Association of Carolinas, it is estimated that around more than 10 million people worldwide are suffering from Parkinson’s disease. Therefore, higher incidences of Parkinson’s disease and other neurological disorders as a result of growing geriatric population is the prime driving factor for the fast-developing global deep brain stimulation devices market. Moreover, increasing investment in research & development from medical device manufacturers are continuously responsible for the growth of global Deep Brain Stimulation market. However, increased risk to post surgery infections and battery life of the devices can affect the growth of Global Deep Brain Stimulation Market. Nonetheless, untapped market and technological advancement in functionality of these devices may generate new opportunities in forecast period. <\/p>\n

Market Segmentation<\/strong><\/p>\n

By Structure Type<\/strong>
Thalamus, Sub-thalamus Nucleus (STN), Pedunculopontine Nucleus (PPN), Globus Pallidus (GPi)<\/p>\n

By Application Type<\/strong>
Parkinson’s Disease, Dystonia, Essential Tremor,  Epilepsy, Tourette Syndrome, Chronic Pain, Obsessive Compulsive Disorders (OCDs), Others<\/p>\n

By End User<\/strong>
Hospitals, Ambulatory Surgical Centers, Others<\/p>\n

By Region:<\/strong> 
North America (US., Canada), Europe (UK., France, Germany, Italy), Asia Pacific (China, Japan, India, Southeast Asia), Latin America (Brazil, Mexico), Middle East and Africa (GCC, Africa, Rest of Middle East and Africa)<\/p>\n

Buy Detail Report @<\/strong> https:\/\/brandessenceresearch.com\/Checkout?report_id=289<\/a> <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Brandessence Market Research and Consulting Pvt ltd.<\/a>
Contact Person:<\/strong> Alan
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +917447409162
Address:<\/strong>Office No 101 City Point, Survey No. 171\/9, Bhekrai Nagar, Near HP Petrol Pump, Opp. HDFC bank Hadapsar-Saswad Road
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/brandessenceresearch.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Deep Brain Stimulation Market is expected to reach USD 1481.39 Million by 2025 with the CAGR of 8.50% over the forecast period. The Deep Brain Stimulation report provides independent information about the Deep Brain Stimulation industry supported by extensive research … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,429,420,416],"tags":[],"class_list":["post-482145","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Hospitality","category-Science","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/482145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=482145"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/482145\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=482145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=482145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=482145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}